W. R. Faber - Concepedia

Author

W. R. Faber

University of Amsterdam

Also Known As

W Faber, W R Faber, W. Faber, W. R. FABER, W. R. Faber, W.R. FABER, W.R. Faber, W. R. Faber, WR Faber, WR. Faber

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

University of Amsterdam Amsterdam UMC Location University of Amsterdam Royal Tropical Institute

About

W. R. Faber is an author at University of Amsterdam specializing in medicine, dermatology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	24	661
2	Health Sciences	2	2	116
3	Public Health	2	2	79
4	Allergy	2	2	35
5	Epidemiology	1	1	57

W. R. Faber

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Application of a polymerase chain reaction for the detection of Mycobacterium leprae in skin tissues M Y de Wit, W. R. Faber, S. R. Krieg, Journal of Clinical Microbiology Pathogen DetectionBacteriologyPathologyDermatologySelective Amplification	1991	103
Immunological Crossreactivity of the <i>Mycobacterium leprae</i> CFP‐10 with its Homologue in <i>Mycobacterium tuberculosis</i> Annemieke Geluk, Krista E. van Meijgaarden, Kees L. M. C. Franken, Scandinavian Journal of Immunology	2004	72
Miltefosine Treatment of<i>Leishmania major</i>Infection: An Observational Study Involving Dutch Military Personnel Returning from Northern Afghanistan P. P. A. M. van Thiel, Tjalling Leenstra, P.À. Kager, Clinical Infectious Diseases	2009	71
Thalidomide Therapy Bernard Naafs, W. R. Faber International Journal of Dermatology Peripheral NeuropathyOpen TrialMedicineTherapeutic ArmamentariumNeuropathic Pain	1985	62
Reversal reaction in borderline leprosy is associated with a polarized shift to type 1-like Mycobacterium leprae T cell reactivity in lesional skin: a follow-up study Claudia E. Verhagen, E A Wierenga, Anita A.M. Buffing, The Journal of Immunology	1997	60
Use of ML dipstick as a tool to classify leprosy patients. Samira Bührer-Sékula, Euzenir Nunes Sarno, Linda Oskam, PubMed DiagnosisPathologyDisease DetectionDermatologyLeprosy Patients	2000	57
Serum levels of interferon-γ, tumour necrosis factor-α, soluble interleukin-6R and soluble cell activation markers for monitoring response to treatment of leprosy reactions Anand M. Iyer, Mochammad Hatta, Rezky A. Usman, Clinical & Experimental Immunology	2007	53
Drug-induced anogenital cicatricial pemphigoid Th. van Joost, W. R. Faber, Haro-Estarriol Manuel British Journal of Dermatology Perianal SkinMedicineRare Primary LocalizationPathologyPharmacotherapy	1980	51
Changing pattern of imported cutaneous leishmaniasis in the Netherlands J. E. Zeegelaar, Willemyn H. Steketee, P. P. A. M. van Thiel, Clinical and Experimental Dermatology Tropical DermatologyParasitic DiseaseWestern CountriesParasitic ProtozoaCutaneous Leishmaniasis	2005	37
Dipstick assay to identify leprosy patients who have an increased risk of relapse Samira Bührer-Sékula, M. G. S. Cunha, Norma T. Foss, Tropical Medicine & International Health	2001	34

Page 1